Anúncio
Anúncio
ERNA
Ernexa Therapeutics Inc. Common Stock
1.30
USDPatrocinado
-0.09
-6.76%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1.34
+0.04
+3.47%
Relatórios de Lucros ERNA
Rácio de surpresa positiva
ERNA separação 11 de 18 últimas estimativas.
61%
Próximo Relatório
Data do Próximo Relatório
10 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/--
Ernexa Therapeutics Inc. Common Stock earnings per share and revenue
On 10 de nov. de 2025, ERNA reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Ernexa Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Ernexa Therapeutics Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Ernexa Therapeutics Inc. Common Stock's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Ernexa Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for 10 de mar. de 2026.
What are the forecasts for Ernexa Therapeutics Inc. Common Stock's next earnings report?
Based on --
analistas, Ernexa Therapeutics Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio